Product
Supplier
Encyclopedia
Inquiry
Fostamatinib   RC10522 buy - large image1
Fostamatinib   RC10522 buy - image1

Fostamatinib RC10522

3 Inquiries

Unit Price:

$1/KG EXW

Get Latest Price
CAS No.:

901119-35-5

Grade:

Pharmaceutical Grade

Content:

99%

Brand:

Royalchem

Packaging:

25kg/drum

Sample Available:

Yes

Price valid (until):

2030-01-01

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
14 days
Qualification:
Main Products:

Pharmaceutical intermediates

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Manufacturer: Hangzhou Royalchem Co.,LTD.

    Website:  www.cnroyalchem.com 

    Hangzhou Royalchem Co., Ltd. was founded by a senior team with profound professional backgrounds in the chemical field, focusing on providing comprehensive chemical products and services. Its business scope covers a wide range, including the sales of core chemical products such as pharmaceutical raw materials and intermediates, food/feed additives, specialty chemicals, dyes & pigments, new catalytic materials, chemical reagents, engineering plastics and synthetic resins. It also engages in the sales of daily chemicals, containers, and import-export business, meeting the needs of clients across multiple sectors. Leveraging the technical accumulation of its professional team and strict quality control, the company has established a stable cooperation network in domestic and international markets. It not only provides high-quality raw material support for industries but also promotes global chemical resource circulation through import-export operations. Adhering to the philosophy of "win-win cooperation," Hangzhou Royalchem Co., Ltd. takes professionalism and integrity as its cornerstone, and sincerely looks forward to working with global partners to drive high-quality development in the chemical industry.


    Hangzhou Royalchem Co., Ltd.  Is focus on services on CMO & CDMO

    Esterification, saponification, hydrolysis, alkylation, halogenation, acetylation, pressurized hydrogenation, and other reactions .


    Preparation and separation of various impurities .


    Development of preparation and purification production processes, salt conversion, liquid preparation post-treatment, etc.



    Items Specifications






    ECHEMI Editorial Reference
    Fostamatinib (R788), a prodrug of the active metabolite R406, is a potent Syk inhibitor with IC50 of 41 nM.
    Fostamatinib has been investigated for the treatment and basic science of Rheumatoid Arthritis and Immune Thrombocytopenic Purpura (ITP). It was approved on April 17, 2018 under the trade name Tavalisse for use in ITP. Fostamatinib has also been granted orphan drug status by the FDA.|Fostamatinib is an orally available small molecule inhibitor of spleen tyrosine kinase that is used to treat chronic immune thrombocytopenia. Fostamatinib is associated with transient and usually mild elevations in serum aminotransferase levels during therapy but has yet to be linked to instances of clinically apparent acute liver injury.|Fostamatinib is a small molecule Syk kinase inhibitor with potential anti-inflammatory and immunomodulating activities. Fostamatinib inhibits Syk kinase-mediated IgG Fc gamma receptor signaling, resulting in inhibition of the activation of mast cells, macrophages, and B-cells and related inflammatory responses and tissue damage. Syk kinase, widely expressed in hematopoietic cells, is a nonreceptor tyrosine kinase that is involved in coupling activated immunoreceptors to signal downstream events that mediate diverse cellular responses, including proliferation, differentiation, and phagocytosis.

    Basic Info
    Product Name:

    Fostamatinib

    Other Name:

    2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one,6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-;6-[[5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one;Fostamatinib;R 788;945745-48-2

    CAS No.:

    901119-35-5

    Molecular Formula:

    C23H26FN6O9P

    InChIKeys:

    InChIKey=GKDRMWXFWHEQQT-UHFFFAOYSA-N

    Molecular Weight:

    580.4595042

    Exact Mass:

    580.46

    EC Number:

    1533716-785-6

    UNII:

    SQ8A3S5101

    NCI Thesaurus Code:

    C95222

    ATC Code:

    B02BX|B - Blood and blood forming organs

    Categories:

    Inhibitor Drugs

    Characteristics
    PSA:

    187

    XLogP3:

    2.12

    Density:

    1.5±0.1 g/cm3

    Boiling Point:

    814.2±75.0 °C at 760 mmHg

    Flash Point:

    446.2±37.1 °C

    Refractive Index:

    1.629

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Pharmaceutical intermediates

    Location:

    Room 336, Building 7, No. 177 Xingqiao North Road, Xingqiao Street, Linping District, Hangzhou

    Payment Terms:

    TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    14 days

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    Less than 5

    Year of Establishment:

    2025

  • Inquiry History
    3 Inquiries
    Country Product Purchase Quantity Date Posted
    Pakistan

    Fostamatinib

    1 KG May 16, 2025
    India

    fostamitinib

    1 G Jun 11, 2026
    India

    Fostamatinib

    20 MG Jun 1, 2026
    Post an enquiry for this product

More from this Seller

pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.